 | • レポートコード：MRC2-11QY06461 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は口蹄疫ワクチンのグローバル市場について調査・分析したレポートです。種類別（緊急ワクチン、従来ワクチン）市場規模、用途別（牛、豚、羊・山羊、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別口蹄疫ワクチンの競争状況、市場シェア ・世界の口蹄疫ワクチン市場：種類別市場規模 2015年-2020年（緊急ワクチン、従来ワクチン） ・世界の口蹄疫ワクチン市場：種類別市場規模予測 2021年-2026年（緊急ワクチン、従来ワクチン） ・世界の口蹄疫ワクチン市場：用途別市場規模 2015年-2020年（牛、豚、羊・山羊、その他） ・世界の口蹄疫ワクチン市場：用途別市場規模予測 2021年-2026年（牛、豚、羊・山羊、その他） ・北米の口蹄疫ワクチン市場分析：米国、カナダ ・ヨーロッパの口蹄疫ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの口蹄疫ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の口蹄疫ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの口蹄疫ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Jinyu Group、Cavet Bio、CAHIC、Tecon Group、Shen Lian、Biogenesis Bago、BIGVET Biotech、Indian Immunologicals、Boehringer Ingelheim、MSD Animal Health、CEVA、Bayer HealthCare、VECOL、Sanofi (Merial)、Brilliant Bio Pharma、VETAL、BVI、LIMOR、ME VAC、Agrovet ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
China is the largest consumption place, with a consumption market share. Following China, South America is the second largest consumption place.
Market Analysis and Insights: Global Foot and Mouth Disease Vaccines Market
The global Foot and Mouth Disease Vaccines market size is projected to reach US$ 966.4 million by 2026, from US$ 875.6 million in 2020, at a CAGR of 9.6%% during 2021-2026.
Global Foot and Mouth Disease Vaccines Scope and Market Size
Foot and Mouth Disease Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Foot and Mouth Disease Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Foot and Mouth Disease Vaccines market is segmented into
Emergency Vaccines
Conventional Vaccines
Segment by Application, the Foot and Mouth Disease Vaccines market is segmented into
Cattle
Pig
Sheep & Goat
Other
Regional and Country-level Analysis
The Foot and Mouth Disease Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Foot and Mouth Disease Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Foot and Mouth Disease Vaccines Market Share Analysis
Foot and Mouth Disease Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Foot and Mouth Disease Vaccines business, the date to enter into the Foot and Mouth Disease Vaccines market, Foot and Mouth Disease Vaccines product introduction, recent developments, etc.
The major vendors covered:
Jinyu Group
Cavet Bio
CAHIC
Tecon Group
Shen Lian
Biogenesis Bago
BIGVET Biotech
Indian Immunologicals
Boehringer Ingelheim
MSD Animal Health
CEVA
Bayer HealthCare
VECOL
Sanofi (Merial)
Brilliant Bio Pharma
VETAL
BVI
LIMOR
ME VAC
Agrovet
1 Study Coverage
1.1 Foot and Mouth Disease Vaccines Product Introduction
1.2 Market Segments
1.3 Key Foot and Mouth Disease Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Foot and Mouth Disease Vaccines Market Size Growth Rate by Type
1.4.2 Emergency Vaccines
1.4.3 Conventional Vaccines
1.5 Market by Application
1.5.1 Global Foot and Mouth Disease Vaccines Market Size Growth Rate by Application
1.5.2 Cattle
1.5.3 Pig
1.5.4 Sheep & Goat
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Foot and Mouth Disease Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Foot and Mouth Disease Vaccines Revenue 2015-2026
2.1.2 Global Foot and Mouth Disease Vaccines Sales 2015-2026
2.2 Global Foot and Mouth Disease Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Foot and Mouth Disease Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Foot and Mouth Disease Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Foot and Mouth Disease Vaccines Competitor Landscape by Players
3.1 Foot and Mouth Disease Vaccines Sales by Manufacturers
3.1.1 Foot and Mouth Disease Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Foot and Mouth Disease Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Foot and Mouth Disease Vaccines Revenue by Manufacturers
3.2.1 Foot and Mouth Disease Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Foot and Mouth Disease Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Foot and Mouth Disease Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Foot and Mouth Disease Vaccines Revenue in 2019
3.2.5 Global Foot and Mouth Disease Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Foot and Mouth Disease Vaccines Price by Manufacturers
3.4 Foot and Mouth Disease Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Foot and Mouth Disease Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Foot and Mouth Disease Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Foot and Mouth Disease Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Foot and Mouth Disease Vaccines Market Size by Type (2015-2020)
4.1.1 Global Foot and Mouth Disease Vaccines Sales by Type (2015-2020)
4.1.2 Global Foot and Mouth Disease Vaccines Revenue by Type (2015-2020)
4.1.3 Foot and Mouth Disease Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Foot and Mouth Disease Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Foot and Mouth Disease Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Foot and Mouth Disease Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Foot and Mouth Disease Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Foot and Mouth Disease Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Foot and Mouth Disease Vaccines Market Size by Application (2015-2020)
5.1.1 Global Foot and Mouth Disease Vaccines Sales by Application (2015-2020)
5.1.2 Global Foot and Mouth Disease Vaccines Revenue by Application (2015-2020)
5.1.3 Foot and Mouth Disease Vaccines Price by Application (2015-2020)
5.2 Foot and Mouth Disease Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Foot and Mouth Disease Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Foot and Mouth Disease Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Foot and Mouth Disease Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Foot and Mouth Disease Vaccines by Country
6.1.1 North America Foot and Mouth Disease Vaccines Sales by Country
6.1.2 North America Foot and Mouth Disease Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Foot and Mouth Disease Vaccines Market Facts & Figures by Type
6.3 North America Foot and Mouth Disease Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Foot and Mouth Disease Vaccines by Country
7.1.1 Europe Foot and Mouth Disease Vaccines Sales by Country
7.1.2 Europe Foot and Mouth Disease Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Foot and Mouth Disease Vaccines Market Facts & Figures by Type
7.3 Europe Foot and Mouth Disease Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Foot and Mouth Disease Vaccines by Region
8.1.1 Asia Pacific Foot and Mouth Disease Vaccines Sales by Region
8.1.2 Asia Pacific Foot and Mouth Disease Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Foot and Mouth Disease Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Foot and Mouth Disease Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Foot and Mouth Disease Vaccines by Country
9.1.1 Latin America Foot and Mouth Disease Vaccines Sales by Country
9.1.2 Latin America Foot and Mouth Disease Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Foot and Mouth Disease Vaccines Market Facts & Figures by Type
9.3 Central & South America Foot and Mouth Disease Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Foot and Mouth Disease Vaccines by Country
10.1.1 Middle East and Africa Foot and Mouth Disease Vaccines Sales by Country
10.1.2 Middle East and Africa Foot and Mouth Disease Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Foot and Mouth Disease Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Foot and Mouth Disease Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Jinyu Group
11.1.1 Jinyu Group Corporation Information
11.1.2 Jinyu Group Description and Business Overview
11.1.3 Jinyu Group Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Jinyu Group Foot and Mouth Disease Vaccines Products Offered
11.1.5 Jinyu Group Related Developments
11.2 Cavet Bio
11.2.1 Cavet Bio Corporation Information
11.2.2 Cavet Bio Description and Business Overview
11.2.3 Cavet Bio Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cavet Bio Foot and Mouth Disease Vaccines Products Offered
11.2.5 Cavet Bio Related Developments
11.3 CAHIC
11.3.1 CAHIC Corporation Information
11.3.2 CAHIC Description and Business Overview
11.3.3 CAHIC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CAHIC Foot and Mouth Disease Vaccines Products Offered
11.3.5 CAHIC Related Developments
11.4 Tecon Group
11.4.1 Tecon Group Corporation Information
11.4.2 Tecon Group Description and Business Overview
11.4.3 Tecon Group Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Tecon Group Foot and Mouth Disease Vaccines Products Offered
11.4.5 Tecon Group Related Developments
11.5 Shen Lian
11.5.1 Shen Lian Corporation Information
11.5.2 Shen Lian Description and Business Overview
11.5.3 Shen Lian Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shen Lian Foot and Mouth Disease Vaccines Products Offered
11.5.5 Shen Lian Related Developments
11.6 Biogenesis Bago
11.6.1 Biogenesis Bago Corporation Information
11.6.2 Biogenesis Bago Description and Business Overview
11.6.3 Biogenesis Bago Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biogenesis Bago Foot and Mouth Disease Vaccines Products Offered
11.6.5 Biogenesis Bago Related Developments
11.7 BIGVET Biotech
11.7.1 BIGVET Biotech Corporation Information
11.7.2 BIGVET Biotech Description and Business Overview
11.7.3 BIGVET Biotech Sales, Revenue and Gross Margin (2015-2020)
11.7.4 BIGVET Biotech Foot and Mouth Disease Vaccines Products Offered
11.7.5 BIGVET Biotech Related Developments
11.8 Indian Immunologicals
11.8.1 Indian Immunologicals Corporation Information
11.8.2 Indian Immunologicals Description and Business Overview
11.8.3 Indian Immunologicals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Indian Immunologicals Foot and Mouth Disease Vaccines Products Offered
11.8.5 Indian Immunologicals Related Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Description and Business Overview
11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Boehringer Ingelheim Foot and Mouth Disease Vaccines Products Offered
11.9.5 Boehringer Ingelheim Related Developments
11.10 MSD Animal Health
11.10.1 MSD Animal Health Corporation Information
11.10.2 MSD Animal Health Description and Business Overview
11.10.3 MSD Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.10.4 MSD Animal Health Foot and Mouth Disease Vaccines Products Offered
11.10.5 MSD Animal Health Related Developments
11.1 Jinyu Group
11.1.1 Jinyu Group Corporation Information
11.1.2 Jinyu Group Description and Business Overview
11.1.3 Jinyu Group Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Jinyu Group Foot and Mouth Disease Vaccines Products Offered
11.1.5 Jinyu Group Related Developments
11.12 Bayer HealthCare
11.12.1 Bayer HealthCare Corporation Information
11.12.2 Bayer HealthCare Description and Business Overview
11.12.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bayer HealthCare Products Offered
11.12.5 Bayer HealthCare Related Developments
11.13 VECOL
11.13.1 VECOL Corporation Information
11.13.2 VECOL Description and Business Overview
11.13.3 VECOL Sales, Revenue and Gross Margin (2015-2020)
11.13.4 VECOL Products Offered
11.13.5 VECOL Related Developments
11.14 Sanofi (Merial)
11.14.1 Sanofi (Merial) Corporation Information
11.14.2 Sanofi (Merial) Description and Business Overview
11.14.3 Sanofi (Merial) Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Sanofi (Merial) Products Offered
11.14.5 Sanofi (Merial) Related Developments
11.15 Brilliant Bio Pharma
11.15.1 Brilliant Bio Pharma Corporation Information
11.15.2 Brilliant Bio Pharma Description and Business Overview
11.15.3 Brilliant Bio Pharma Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Brilliant Bio Pharma Products Offered
11.15.5 Brilliant Bio Pharma Related Developments
11.16 VETAL
11.16.1 VETAL Corporation Information
11.16.2 VETAL Description and Business Overview
11.16.3 VETAL Sales, Revenue and Gross Margin (2015-2020)
11.16.4 VETAL Products Offered
11.16.5 VETAL Related Developments
11.17 BVI
11.17.1 BVI Corporation Information
11.17.2 BVI Description and Business Overview
11.17.3 BVI Sales, Revenue and Gross Margin (2015-2020)
11.17.4 BVI Products Offered
11.17.5 BVI Related Developments
11.18 LIMOR
11.18.1 LIMOR Corporation Information
11.18.2 LIMOR Description and Business Overview
11.18.3 LIMOR Sales, Revenue and Gross Margin (2015-2020)
11.18.4 LIMOR Products Offered
11.18.5 LIMOR Related Developments
11.19 ME VAC
11.19.1 ME VAC Corporation Information
11.19.2 ME VAC Description and Business Overview
11.19.3 ME VAC Sales, Revenue and Gross Margin (2015-2020)
11.19.4 ME VAC Products Offered
11.19.5 ME VAC Related Developments
11.20 Agrovet
11.20.1 Agrovet Corporation Information
11.20.2 Agrovet Description and Business Overview
11.20.3 Agrovet Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Agrovet Products Offered
11.20.5 Agrovet Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Foot and Mouth Disease Vaccines Market Estimates and Projections by Region
12.1.1 Global Foot and Mouth Disease Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Foot and Mouth Disease Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Foot and Mouth Disease Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Foot and Mouth Disease Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Foot and Mouth Disease Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Foot and Mouth Disease Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Foot and Mouth Disease Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Foot and Mouth Disease Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Foot and Mouth Disease Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Foot and Mouth Disease Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Foot and Mouth Disease Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Foot and Mouth Disease Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Foot and Mouth Disease Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Foot and Mouth Disease Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Foot and Mouth Disease Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Foot and Mouth Disease Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Foot and Mouth Disease Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Foot and Mouth Disease Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Foot and Mouth Disease Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Foot and Mouth Disease Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Foot and Mouth Disease Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Foot and Mouth Disease Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Foot and Mouth Disease Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Foot and Mouth Disease Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Foot and Mouth Disease Vaccines Market Segments
Table 2. Ranking of Global Top Foot and Mouth Disease Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Foot and Mouth Disease Vaccines Market Size Growth Rate by Type 2020-2026 (K L) & (US$ Million)
Table 4. Major Manufacturers of Emergency Vaccines
Table 5. Major Manufacturers of Conventional Vaccines
Table 6. Global Foot and Mouth Disease Vaccines Market Size Growth Rate by Application 2020-2026 (K L)
Table 7. Global Foot and Mouth Disease Vaccines Market Size by Region (K L) & (US$ Million): 2020 VS 2026
Table 8. Global Foot and Mouth Disease Vaccines Sales by Regions 2015-2020 (K L)
Table 9. Global Foot and Mouth Disease Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Foot and Mouth Disease Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Foot and Mouth Disease Vaccines Sales by Manufacturers (2015-2020) (K L)
Table 12. Global Foot and Mouth Disease Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Foot and Mouth Disease Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Foot and Mouth Disease Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Foot and Mouth Disease Vaccines as of 2019)
Table 15. Foot and Mouth Disease Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Foot and Mouth Disease Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Foot and Mouth Disease Vaccines Price (2015-2020) (USD/L)
Table 18. Foot and Mouth Disease Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Foot and Mouth Disease Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Foot and Mouth Disease Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Foot and Mouth Disease Vaccines Sales by Type (2015-2020) (K L)
Table 23. Global Foot and Mouth Disease Vaccines Sales Share by Type (2015-2020)
Table 24. Global Foot and Mouth Disease Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Foot and Mouth Disease Vaccines Revenue Share by Type (2015-2020)
Table 26. Foot and Mouth Disease Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/L)
Table 27. Global Foot and Mouth Disease Vaccines Sales by Application (2015-2020) (K L)
Table 28. Global Foot and Mouth Disease Vaccines Sales Share by Application (2015-2020)
Table 29. North America Foot and Mouth Disease Vaccines Sales by Country (2015-2020) (K L)
Table 30. North America Foot and Mouth Disease Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Foot and Mouth Disease Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Foot and Mouth Disease Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Foot and Mouth Disease Vaccines Sales by Type (2015-2020) (K L)
Table 34. North America Foot and Mouth Disease Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Foot and Mouth Disease Vaccines Sales by Application (2015-2020) (K L)
Table 36. North America Foot and Mouth Disease Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Foot and Mouth Disease Vaccines Sales by Country (2015-2020) (K L)
Table 38. Europe Foot and Mouth Disease Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Foot and Mouth Disease Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Foot and Mouth Disease Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Foot and Mouth Disease Vaccines Sales by Type (2015-2020) (K L)
Table 42. Europe Foot and Mouth Disease Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Foot and Mouth Disease Vaccines Sales by Application (2015-2020) (K L)
Table 44. Europe Foot and Mouth Disease Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Foot and Mouth Disease Vaccines Sales by Region (2015-2020) (K L)
Table 46. Asia Pacific Foot and Mouth Disease Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Foot and Mouth Disease Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Foot and Mouth Disease Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Foot and Mouth Disease Vaccines Sales by Type (2015-2020) (K L)
Table 50. Asia Pacific Foot and Mouth Disease Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Foot and Mouth Disease Vaccines Sales by Application (2015-2020) (K L)
Table 52. Asia Pacific Foot and Mouth Disease Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Foot and Mouth Disease Vaccines Sales by Country (2015-2020) (K L)
Table 54. Latin America Foot and Mouth Disease Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Foot and Mouth Disease Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Foot and Mouth Disease Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Foot and Mouth Disease Vaccines Sales by Type (2015-2020) (K L)
Table 58. Latin America Foot and Mouth Disease Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Foot and Mouth Disease Vaccines Sales by Application (2015-2020) (K L)
Table 60. Latin America Foot and Mouth Disease Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Foot and Mouth Disease Vaccines Sales by Country (2015-2020) (K L)
Table 62. Middle East and Africa Foot and Mouth Disease Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Foot and Mouth Disease Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Foot and Mouth Disease Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Foot and Mouth Disease Vaccines Sales by Type (2015-2020) (K L)
Table 66. Middle East and Africa Foot and Mouth Disease Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Foot and Mouth Disease Vaccines Sales by Application (2015-2020) (K L)
Table 68. Middle East and Africa Foot and Mouth Disease Vaccines Sales Market Share by Application (2015-2020)
Table 69. Jinyu Group Corporation Information
Table 70. Jinyu Group Description and Major Businesses
Table 71. Jinyu Group Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 72. Jinyu Group Product
Table 73. Jinyu Group Recent Development
Table 74. Cavet Bio Corporation Information
Table 75. Cavet Bio Description and Major Businesses
Table 76. Cavet Bio Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 77. Cavet Bio Product
Table 78. Cavet Bio Recent Development
Table 79. CAHIC Corporation Information
Table 80. CAHIC Description and Major Businesses
Table 81. CAHIC Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 82. CAHIC Product
Table 83. CAHIC Recent Development
Table 84. Tecon Group Corporation Information
Table 85. Tecon Group Description and Major Businesses
Table 86. Tecon Group Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 87. Tecon Group Product
Table 88. Tecon Group Recent Development
Table 89. Shen Lian Corporation Information
Table 90. Shen Lian Description and Major Businesses
Table 91. Shen Lian Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 92. Shen Lian Product
Table 93. Shen Lian Recent Development
Table 94. Biogenesis Bago Corporation Information
Table 95. Biogenesis Bago Description and Major Businesses
Table 96. Biogenesis Bago Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 97. Biogenesis Bago Product
Table 98. Biogenesis Bago Recent Development
Table 99. BIGVET Biotech Corporation Information
Table 100. BIGVET Biotech Description and Major Businesses
Table 101. BIGVET Biotech Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 102. BIGVET Biotech Product
Table 103. BIGVET Biotech Recent Development
Table 104. Indian Immunologicals Corporation Information
Table 105. Indian Immunologicals Description and Major Businesses
Table 106. Indian Immunologicals Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 107. Indian Immunologicals Product
Table 108. Indian Immunologicals Recent Development
Table 109. Boehringer Ingelheim Corporation Information
Table 110. Boehringer Ingelheim Description and Major Businesses
Table 111. Boehringer Ingelheim Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 112. Boehringer Ingelheim Product
Table 113. Boehringer Ingelheim Recent Development
Table 114. MSD Animal Health Corporation Information
Table 115. MSD Animal Health Description and Major Businesses
Table 116. MSD Animal Health Foot and Mouth Disease Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 117. MSD Animal Health Product
Table 118. MSD Animal Health Recent Development
Table 119. CEVA Corporation Information
Table 120. CEVA Description and Major Businesses
Table 121. CEVA Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 122. CEVA Product
Table 123. CEVA Recent Development
Table 124. Bayer HealthCare Corporation Information
Table 125. Bayer HealthCare Description and Major Businesses
Table 126. Bayer HealthCare Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 127. Bayer HealthCare Product
Table 128. Bayer HealthCare Recent Development
Table 129. VECOL Corporation Information
Table 130. VECOL Description and Major Businesses
Table 131. VECOL Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 132. VECOL Product
Table 133. VECOL Recent Development
Table 134. Sanofi (Merial) Corporation Information
Table 135. Sanofi (Merial) Description and Major Businesses
Table 136. Sanofi (Merial) Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 137. Sanofi (Merial) Product
Table 138. Sanofi (Merial) Recent Development
Table 139. Brilliant Bio Pharma Corporation Information
Table 140. Brilliant Bio Pharma Description and Major Businesses
Table 141. Brilliant Bio Pharma Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 142. Brilliant Bio Pharma Product
Table 143. Brilliant Bio Pharma Recent Development
Table 144. VETAL Corporation Information
Table 145. VETAL Description and Major Businesses
Table 146. VETAL Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 147. VETAL Product
Table 148. VETAL Recent Development
Table 149. BVI Corporation Information
Table 150. BVI Description and Major Businesses
Table 151. BVI Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 152. BVI Product
Table 153. BVI Recent Development
Table 154. LIMOR Corporation Information
Table 155. LIMOR Description and Major Businesses
Table 156. LIMOR Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 157. LIMOR Product
Table 158. LIMOR Recent Development
Table 159. ME VAC Corporation Information
Table 160. ME VAC Description and Major Businesses
Table 161. ME VAC Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 162. ME VAC Product
Table 163. ME VAC Recent Development
Table 164. Agrovet Corporation Information
Table 165. Agrovet Description and Major Businesses
Table 166. Agrovet Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 167. Agrovet Product
Table 168. Agrovet Recent Development
Table 169. Global Foot and Mouth Disease Vaccines Sales Forecast by Regions (2021-2026) (K L)
Table 170. Global Foot and Mouth Disease Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 171. Global Foot and Mouth Disease Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 172. Global Foot and Mouth Disease Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 173. North America: Foot and Mouth Disease Vaccines Sales Forecast by Country (2021-2026) (K L)
Table 174. North America: Foot and Mouth Disease Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Europe: Foot and Mouth Disease Vaccines Sales Forecast by Country (2021-2026) (K L)
Table 176. Europe: Foot and Mouth Disease Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Asia Pacific: Foot and Mouth Disease Vaccines Sales Forecast by Region (2021-2026) (K L)
Table 178. Asia Pacific: Foot and Mouth Disease Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 179. Latin America: Foot and Mouth Disease Vaccines Sales Forecast by Country (2021-2026) (K L)
Table 180. Latin America: Foot and Mouth Disease Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Middle East and Africa: Foot and Mouth Disease Vaccines Sales Forecast by Country (2021-2026) (K L)
Table 182. Middle East and Africa: Foot and Mouth Disease Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 184. Key Challenges
Table 185. Market Risks
Table 186. Main Points Interviewed from Key Foot and Mouth Disease Vaccines Players
Table 187. Foot and Mouth Disease Vaccines Customers List
Table 188. Foot and Mouth Disease Vaccines Distributors List
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Foot and Mouth Disease Vaccines Product Picture
Figure 2. Global Foot and Mouth Disease Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Emergency Vaccines Product Picture
Figure 4. Conventional Vaccines Product Picture
Figure 5. Global Foot and Mouth Disease Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Cattle
Figure 7. Pig
Figure 8. Sheep & Goat
Figure 9. Other
Figure 10. Foot and Mouth Disease Vaccines Report Years Considered
Figure 11. Global Foot and Mouth Disease Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Foot and Mouth Disease Vaccines Sales 2015-2026 (K L)
Figure 13. Global Foot and Mouth Disease Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Foot and Mouth Disease Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Foot and Mouth Disease Vaccines Sales Market Share by Region in 2019
Figure 16. Global Foot and Mouth Disease Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Foot and Mouth Disease Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Foot and Mouth Disease Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Foot and Mouth Disease Vaccines Revenue in 2019
Figure 20. Foot and Mouth Disease Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Foot and Mouth Disease Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Foot and Mouth Disease Vaccines Sales Market Share by Type in 2019
Figure 23. Global Foot and Mouth Disease Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Foot and Mouth Disease Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Foot and Mouth Disease Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Foot and Mouth Disease Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Foot and Mouth Disease Vaccines Sales Market Share by Application in 2019
Figure 28. Global Foot and Mouth Disease Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Foot and Mouth Disease Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Foot and Mouth Disease Vaccines Sales Growth Rate 2015-2020 (K L)
Figure 31. North America Foot and Mouth Disease Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Foot and Mouth Disease Vaccines Sales Market Share by Country in 2019
Figure 33. North America Foot and Mouth Disease Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 35. U.S. Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 37. Canada Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Foot and Mouth Disease Vaccines Market Share by Type in 2019
Figure 39. North America Foot and Mouth Disease Vaccines Market Share by Application in 2019
Figure 40. Europe Foot and Mouth Disease Vaccines Sales Growth Rate 2015-2020 (K L)
Figure 41. Europe Foot and Mouth Disease Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Foot and Mouth Disease Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Foot and Mouth Disease Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 45. Germany Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 47. France Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 49. U.K. Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 51. Italy Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 53. Russia Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Foot and Mouth Disease Vaccines Market Share by Type in 2019
Figure 55. Europe Foot and Mouth Disease Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Foot and Mouth Disease Vaccines Sales Growth Rate 2015-2020 (K L)
Figure 57. Asia Pacific Foot and Mouth Disease Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Foot and Mouth Disease Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Foot and Mouth Disease Vaccines Revenue Market Share by Region in 2019
Figure 60. China Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 61. China Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 63. Japan Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 65. South Korea Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 67. India Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 69. Australia Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 71. Taiwan Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 73. Indonesia Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 75. Thailand Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 77. Malaysia Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 79. Philippines Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 81. Vietnam Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Foot and Mouth Disease Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Foot and Mouth Disease Vaccines Market Share by Application in 2019
Figure 84. Latin America Foot and Mouth Disease Vaccines Sales Growth Rate 2015-2020 (K L)
Figure 85. Latin America Foot and Mouth Disease Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Foot and Mouth Disease Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Foot and Mouth Disease Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 89. Mexico Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 91. Brazil Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 93. Argentina Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Foot and Mouth Disease Vaccines Market Share by Type in 2019
Figure 95. Latin America Foot and Mouth Disease Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Foot and Mouth Disease Vaccines Sales Growth Rate 2015-2020 (K L)
Figure 97. Middle East and Africa Foot and Mouth Disease Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Foot and Mouth Disease Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Foot and Mouth Disease Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 101. Turkey Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 103. Saudi Arabia Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Foot and Mouth Disease Vaccines Sales Growth Rate (2015-2020) (K L)
Figure 105. U.A.E Foot and Mouth Disease Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Foot and Mouth Disease Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Foot and Mouth Disease Vaccines Market Share by Application in 2019
Figure 108. North America Foot and Mouth Disease Vaccines Sales Growth Rate Forecast (2021-2026) (K L)
Figure 109. North America Foot and Mouth Disease Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Foot and Mouth Disease Vaccines Sales Growth Rate Forecast (2021-2026) (K L)
Figure 111. Europe Foot and Mouth Disease Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Foot and Mouth Disease Vaccines Sales Growth Rate Forecast (2021-2026) (K L)
Figure 113. Asia Pacific Foot and Mouth Disease Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Foot and Mouth Disease Vaccines Sales Growth Rate Forecast (2021-2026) (K L)
Figure 115. Latin America Foot and Mouth Disease Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Foot and Mouth Disease Vaccines Sales Growth Rate Forecast (2021-2026) (K L)
Figure 117. Middle East and Africa Foot and Mouth Disease Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
口蹄疫（FMD）ワクチンの世界市場（～2026年） An drug that provide immunity to the FMD. Growing livestock population and increasing demand for animal products are some of the factors contributing to the increased adoption of these vaccines globally. Livestock and zoonotic diseases are increasing over the past few decades owing to factors such a…- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- mRNA癌ワクチン・治療薬の世界市場（～2026年） mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…